Aldeyra Therapeutics (NASDAQ:ALDX) Coverage Initiated at StockNews.com
StockNews.com began coverage on shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) in a report released on Thursday. The brokerage issued a sell rating on the biotechnology company’s stock. Other equities research analysts have also issued reports about the company. Oppenheimer reissued an outperform rating and issued a $14.00 price target on shares of Aldeyra […]